
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Supplements and Featured Publications
about 27 years ago
Participating Facultyabout 27 years ago
Epidemiology of Pneumococcal Disease: Rationale for and Efficacy of PnC7about 27 years ago
Bibliography





